Cargando…

Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes

Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in patients with type 2 diabetes (T2D). Historical concerns about cardiovascular (CV) risks associated with certain glucose-lowering medications gave rise to the introduction of cardiovascular outcomes trials (CVOTs). Initi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davies, Melanie J., Drexel, Heinz, Jornayvaz, François R., Pataky, Zoltan, Seferović, Petar M., Wanner, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351217/ https://www.ncbi.nlm.nih.gov/pubmed/35927730 http://dx.doi.org/10.1186/s12933-022-01575-9

Ejemplares similares

Paradigm Shift or Shifting Paradigm for Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2012)

Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity
por: Asrih, Mohamed, et al.
Publicado: (2022)

Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
por: Luo, Fei, et al.
Publicado: (2019)

Effectiveness of Therapeutic Patient Education Interventions in Obesity and Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Correia, Jorge C., et al.
Publicado: (2022)

Paradigm shift – For effective management of diabetic retinopathy and glaucoma
por: Ravilla, Thulasiraj
Publicado: (2018)

Chrononutrition Applied to Diabetes Management: A Paradigm Shift Long Delayed
por: Mezitis, Nicholas H.E., et al.
Publicado: (2018)

Major Depressive Disorder: Current Advances and Paradigm Shifts
por: Kim, Yong-Ku
Publicado: (2020)

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management
por: Ceriello, Antonio, et al.
Publicado: (2021)

Shifting Sugars and Shifting Paradigms
por: Siegal, Mark L.
Publicado: (2015)

NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
por: Nascè, Alberto, et al.
Publicado: (2022)

Advances in glaucoma surgery: Paradigm shift in management
por: Pathak-Ray, Vanita
Publicado: (2016)

Paradigm Shift in the Management of the Atrophic Posterior Maxilla
por: Nedir, Rabah, et al.
Publicado: (2014)

Staghorn calculi: Understanding the paradigm shift in management
por: Desai, Mahesh, et al.
Publicado: (2020)

A New Paradigm Shift in Gastroparesis Management
por: Mekaroonkamol, Parit, et al.
Publicado: (2022)

Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes
por: Schernthaner, Guntram, et al.
Publicado: (2017)

Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
por: Shehadeh, Naim, et al.
Publicado: (2018)

A Paradigm Shift in the Treatment of Type 2 Diabetes and Heart Failure
por: Sano, Motoaki
Publicado: (2020)

New Agents in the Management of Type 2 Diabetes: Do They Provide an Opportunity for a Shift in the Treatment Paradigm?
por: Valdez, Connie A.
Publicado: (2008)

A paradigm shift
Publicado: (2009)

Shifting Paradigms in Cardiovascular Therapeutic Strategies During the COVID-19 Era
por: Kornowski, Ran
Publicado: (2020)

Shifting the Paradigm: Monitoring Access in Medicare Managed Care
por: Docteur, Elizabeth R., et al.
Publicado: (1996)

Paradigm shift in head and neck oncology patient management
por: van Linden van den Heuvell, Chiquit, et al.
Publicado: (2017)

A paradigm shift in pulmonary arterial hypertension management
por: Rubin, Lewis J., et al.
Publicado: (2013)

Implications of the paradigm shift in management of Helicobacter pylori infections
por: Graham, David Y.
Publicado: (2023)

Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
por: Memaj, Plator, et al.
Publicado: (2022)

Data on the impact of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events
por: Saely, Christoph H., et al.
Publicado: (2018)

Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?
por: Arabi, Amir, et al.
Publicado: (2022)

Introduction to the special issue entitled ‘Heart failure management of the elderly patient: focus on frailty, sarcopenia, cachexia, and dementia’
por: Seferović, Petar M
Publicado: (2019)

Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a Swiss population
por: de Mestral, Carlos, et al.
Publicado: (2020)

Paradigm shift : the new promise of information technology
por: Tapscott, Don, 1947-
Publicado: (1993)

Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies
por: Kosinski, Christophe, et al.
Publicado: (2017)

Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report
por: Seferovic, Jelena P., et al.
Publicado: (2021)

Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)
por: Schernthaner, Guntram, et al.
Publicado: (2017)

A Paradigm Shift in the Management Approaches of Proliferative Diabetic Retinopathy: Role of Anti-VEGF Therapy
por: Raman, Rajiv, et al.
Publicado: (2022)

Shifting the Disease Management Paradigm From Glucose: What are the pros?
por: Stirban, Alin, et al.
Publicado: (2009)

Shifting the Disease Management Paradigm From Glucose: What are the cons?
por: Hanefeld, Markolf, et al.
Publicado: (2009)

Beyond COVID-19—a paradigm shift in infection management?
por: Vehreschild, Maria J G T, et al.
Publicado: (2021)

Medical management of thyroid eye disease – A paradigm shift
por: Honavar, Santosh G
Publicado: (2020)

The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics—Definition, Current Advances, and Future Directions
por: Gopal, Nikhil, et al.
Publicado: (2022)

Paradigm Shift in Life Sciences
por: Kim, Kisoon
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o3ke2hte8ur2nmkp306b1idalf